Log In

Forgot Password?

OR

Not a member? Continue as a nonmember.

Become a Member

By becoming a member of the AAN, you can receive exclusive information to help you at every stage of your career. Benefits include:

Join Now See All Benefits

Loading... please wait

2022 Annual Meeting | S9 - Neuromodulation and Alternatives to Reduce Opioid Use in Pain Management

Monday 04/04/22
01:00 PM - 01:50 PM PDT Add To Calendar
This program will be presented both in-person and online
This program will be available in the meeting's On Demand product.
Scientific Platform Session
Pain
0.75 CME credit

Program Materials Program Evaluations

Event Timeline
01:00 PM - 01:12 PM PDT Speaker 2022 Mitchell B. Max Award for Neuropathic Pain: This award recognizes an individual for outstanding work in the field of neuropathic pain for either a single contribution or for lifetime achievement.
John Markman, MD, FAAN
01:00 PM - 01:00 PM PDT Speaker walk in slides
John Markman, MD, FAAN
01:12 PM - 01:24 PM PDT Abstract 002 - Pramipexole Improves the Analgesic Properties of Low-dose Morphine in the Treatment of Acute Pain
Ryan Patton
01:24 PM - 01:36 PM PDT Abstract 003 - Repetitive Transcranial Magnetic Stimulation for the Treatment of Fibromyalgia: An open label clinical trial
Nilson Nogueira Mendes Neto, MD
01:36 PM - 01:48 PM PDT Abstract 004 - Non-Invasive Brain Stimulation For Diabetic Neuropathic Pain
Ciro Ramos Estebanez, MD, PhD, MBA, FAAN
Faculty Disclosures
Felipe Fregni Felipe Fregni has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Neurive.
Ciro Ramos Estebanez, MD, PhD, MBA, FAAN The institution of Dr. Ramos Estebanez has received research support from NIH. Dr. Ramos Estebanez has received intellectual property interests from a discovery or technology relating to health care.
Uri Eden No disclosure on file
Krishnakant Shah Aka Khandelwal Mr. Shah Aka Khandelwal has nothing to disclose.
Persen Sukpornchairak, MD Dr. Sukpornchairak has nothing to disclose.
Laura Dipietro Dr. Dipietro has received personal compensation for serving as an employee of Highland Instruments. Dr. Dipietro has received stock or an ownership interest from Highland Instruments. The institution of Dr. Dipietro has received research support from NIH. Dr. Dipietro has received intellectual property interests from a discovery or technology relating to health care. Dr. Dipietro has received intellectual property interests from a discovery or technology relating to health care.
Anisha Yarlagadda, Other Miss Yarlagadda has nothing to disclose.
Gautham Chitturu, Other Mr. Chitturu has nothing to disclose.
Stefan Clemens, PhD Prof. Clemens has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. The institution of Prof. Clemens has received research support from National Science Foundation. Prof. Clemens has received intellectual property interests from a discovery or technology relating to health care.
Ryan Patton Mr. Patton has nothing to disclose.
Poty Jales, MD,PhD Dr. Jales has nothing to disclose.
Christopher Connor, MD,PhD Dr. Connor has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Teleflex. Dr. Connor has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Morrison Mahoney. The institution of Dr. Connor has received research support from NIH/NIGMS.
Nilson *use 361878 Nogueira Mendes Neto, MD Dr. Nogueira Mendes Neto has nothing to disclose.
Ryan Tatton Mr. Tatton has nothing to disclose.
Allison Mainhart, Other Ms. Mainhart has nothing to disclose.
Salim Hayek No disclosure on file
Tim Wagner Dr. Wagner has received personal compensation for serving as an employee of Highland Instruments. Dr. Wagner has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Highland instruments. Dr. Wagner has received stock or an ownership interest from Highland Instruments. The institution of Dr. Wagner has received research support from NIH. The institution of Dr. Wagner has received research support from Private Investors in Highland Instruments. Dr. Wagner has received intellectual property interests from a discovery or technology relating to health care. Dr. Wagner has received intellectual property interests from a discovery or technology relating to health care. Dr. Wagner has received personal compensation in the range of $500-$4,999 for serving as a Grant Reviewer with NIH.
Paola Gonzalez Mego, MD Dr. Gonzalez Mego has nothing to disclose.
Jessika Thais da Silva Maia Jessika Thais da Silva Maia has nothing to disclose.
Kori Brewer Kori Brewer has nothing to disclose.
John Markman, MD, FAAN Dr. Markman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Clexio Biosciences. Dr. Markman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Eliem Therapeutics. Dr. Markman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Trevena. Dr. Markman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Grunenthal. Dr. Markman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Grunenthal. Dr. Markman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lateral Pharma. Dr. Markman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Avenue Therapeutics. Dr. Markman has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Markman has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Allergan. Dr. Markman has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Regenacy. Dr. Markman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Tonix Pharmaceuticals. Dr. Markman has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Flowonix. Dr. Markman has stock in Yellowblack Corporation.
J. D. Bartleson, MD, FAAN Dr. Bartleson has nothing to disclose.
Ligia V. Onofrei, MD Dr. Onofrei has nothing to disclose.
Nilson Nogueira Mendes Neto, MD Dr. Nogueira Mendes Neto has nothing to disclose.